VLE-IOV: Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
Study Details
Study Description
Brief Summary
The purpose of this study is to assess the interobserver agreement (IOV) for pancreatico-biliary Volumetric Laser Endomicroscopy (VLE) de-identified clips using the new VLE criteria.
This is an Interobserver study to validate VLE criteria for indeterminate biliary and pancreatic duct strictures and evaluate impact on clinical management.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
|
Detailed Description
Objective: Validate diagnostic impact of VLE diagnostic accuracy on clinical management
Primary Objectives:
-
Interobserver study for criteria validation and accuracy, Positive predictive value (PPV) and Negative predictive value (NPV), sensitivity and specificity.
-
Evaluation of VLE diagnostics on clinical management (increased accuracy/faster detection)
-
Determination of learning curve to standardize credentialing for endoscopists to use and interpret VLE imaging for biliary/pancreatic treatment management.
- Hypotheses / Research Question(s) The new VLE criteria for biliary and pancreatic duct strictures increase accuracy, thus leading to substantial impact on clinical management (Screening and Treatment)
Study Design (2 phase):
-
Phase 1: Primary Objective 1 and 2 part of the study will be completed.
-
Phase 2: Primary Objective 3 of the study will be conducted within 1 month.
Study Timeline: 3 months post WIRB approval. Sample size: 40 VLE Clips of at least 20 seconds featuring one or more the VLE criteria. All clips will have confirmed diagnosis for accuracy analysis. All clips will be de-identified. All clips will be removed from RedCAP and other secure cloud storage upon completion of study.
Clips will be supplied by NinePoint Medical, the company behind VLE OCT. All VLE clips will be from a dataset of clips collected from adults > 18 and who underwent Endoscopic retrograde cholangiopancreatography (ERCP) with indeterminate biliary stricture indications. The clips are chosen based on the quality of the clips, duration, final diagnosis and presence of either benign or malignant criteria.
Investigators: Up to 30 Expert and non-expert endoscopists currently using VLE
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Expert Endoscopists Experienced Endoscopists with significant user experience with Volumetric Laser Endomicroscopy for bile duct/pancreatic duct strictures |
Other: Interobserver agreement or Interrater agreement
Interobserver agreement or Interrater agreement using 9 visual criteria for diagnosing VLE clips that feature indeterminate biliary or pancreatic duct strictures
|
None-Expert Endoscopists Experienced Endoscopists with non-significant or beignner user experience with Volumetric Laser Endomicroscopy for bile duct/pancreatic duct strictures |
Other: Interobserver agreement or Interrater agreement
Interobserver agreement or Interrater agreement using 9 visual criteria for diagnosing VLE clips that feature indeterminate biliary or pancreatic duct strictures
|
Outcome Measures
Primary Outcome Measures
- Interobserver agreement and diagnostic accuracy [2 months]
Interobserver study for criteria validation and accuracy, PPV and NPV, sensitivity and specificity
- Frequency and type of criteria visually identified on malignant VLE clips [2 months]
Correlation analysis of any of the 9 visual criteria with malignancy diagnosis as determined by endoscopist
Secondary Outcome Measures
- Number of procedures needed to view and conduct to use VLE for diagnostic confirmation [2 months]
Learning curve using CUSUM analysis to standardize credentialing for endoscopists to use and interpret VLE imaging for biliary/pancreatic treatment management proficiently.
Eligibility Criteria
Criteria
Inclusion Criteria:
VLE clips featuring indeterminate biliary or pancreatic duct stricture with confirmed diagnosis on pathology -
Exclusion Criteria:
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Innovative Digestive Health Education & Research Inc | New Brunswick | New Jersey | United States | 08901 |
Sponsors and Collaborators
- Innovative Digestive Health Education and Research Inc
- NinePoint Medical
Investigators
- Principal Investigator: Michel Kahaleh, MD, Innovative Digestive Health Education and Research Inc
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2565207-44318141